Stella Gaenger

Albert Einstein Allee 11
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Leucine-rich α-2 glycoprotein 1 is associated with increased mortality risk in patients with peripheral artery disease.

Leucine-rich α-2 glycoprotein 1 is associated with increased mortality risk in patients with peripheral artery disease.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: June 04, 2025

The differential effects of CBD and CBDA on viability and mRNA expression in colorectal cancer cells.

The differential effects of CBD and CBDA on viability and mRNA expression in colorectal cancer cells.

Journal: Journal of cannabis research

Published: April 17, 2025

Serum leucine-rich α-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.

Serum leucine-rich α-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.

Journal: Atherosclerosis

Published: April 02, 2025

Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease.

Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease.

Journal: Journal of clinical medicine

Published: July 26, 2023

Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.

Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.

Journal: Clinical biochemistry

Published: June 28, 2023

Myricetin attenuates hypoxia-induced inflammation in human adipocytes.

Myricetin attenuates hypoxia-induced inflammation in human adipocytes.

Journal: Molecular biology reports

Published: June 15, 2023

Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients.

Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients.

Journal: Breast cancer research and treatment

Published: May 10, 2023

Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.

Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients.

Journal: Journal of cancer research and clinical oncology

Published: November 10, 2022

Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease.

Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease.

Journal: International journal of cardiology

Published: June 02, 2022

Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography.

Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography.

Journal: Data in brief

Published: March 03, 2022

Evaluation of the association of serum glypican-4 with prevalent and future kidney function.

Evaluation of the association of serum glypican-4 with prevalent and future kidney function.

Journal: Scientific reports

Published: February 04, 2022

Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors.

Clonal Evolution in Patients with Hormone Receptor Positive, HER-2 Negative Breast Cancer Treated with Chemotherapy or CDK4/6 Inhibitors.

Journal: Oncology research and treatment

Published: December 10, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026